VIRUN and Vital Expand Finished Product Applications

WALNUT, Calif.VIRUN and Vital Pharmaceuticals expanded its vertically-integrated solutions for finished product applications containing OmegaH20® Omega-3 EPA DHA, PQQwater, Coenzyme Clear® and other patented/patent pending products and technologies.

VIRUN expanded its production operations to support the growing demand of FUXIONS ingredients through the Specialty Products Division at Hormel Foods. The new current good manufacturing practices (cGMP) facility can produce up to 20,000 gallons a day of its products. Utilizing VIRUNs patent and patent-pending portfolio, this new facility will allow extended efficiency in processing, higher yield production and will also facilitate VIRUNs patent-pending HCO3 extraction process. This expansion will be adjacent to Vital Pharmaceuticals and will allow a two-step process from raw material manufacturing into finished product application. 

 There is growing interest for FUXIONS ingredients, in particular with supplement beverage applications that demand differentiation in the market place," said Nicole Shute, marketing manager, Specialty Products at Hormel Foods. "This expansion and partnership will assist FUXIONS application development with finished product actualization."

Vital Pharmaceuticals has a 200,000-square foot facility that produces liquid shots, multi-serving liquid products, including proprietary three-, eight-, 16- and 20-ounce beverages in multiple rotary or piston filling lines. Vital Pharmaceuticals also developed in-house proprietary encapsulation technologies that enable an immediate and sustainable tri-phase pharmacokinetic delivery.

Vital Pharmaceuticals has funded 22 double blind, placebo-controlled human studies on its products  and has recently developed their own in-house nutrition bar manufacturing to allow source omega-3 EPA and DHA claims in a single serving, whole food bar. The partnership will allow customers to produce the raw material omega-3 EPA DHA or other water insoluble component and manufacture their finished food, liquid capsules, powders emulsion concentrates and beverages at one cGMP biotech and food processing block in Florida. Advantages of these products will include all-natural, no preservatives, no undeclared additives and only generally recognized as safe (GRAS) clean label ingredients for direct food use.

"VIRUNs integration with Vital Pharmaceuticals just makes sense from many different perspectives ," said Jack Owoc, member of the board of directors. "Together we have an innovation wheel that is going to produce dozens of $100 million-plus beverages, supplements and nutrition products. More importantly, the big picture Vital/Virun vision is aligned to produce finished inventions backed by a scientific explosion of innovation in order to improve the health and quality of life of billions of individuals."

VIRUN and Vital Pharmaceuticals will be at SupplySide West Global Expo and Conference in Las Vegas this month.